11 results  1 of 1 

1 Comparison of the healing effects of mesazaline and Ganoderma lucidum in acetic acid-induced colitis in rats
Hüseyin Özden, Yaşar Şahin, Asuman Kilitçi, Gökhan Karaca, Muhammed Gömeç, Ahmet Yildiz, Cahit Uçar
Ann Surg Treat Res.2022;102(1):29-35.   Published online 2022 January 3     DOI: http://dx.doi.org/10.4174/astr.2022.102.1.29
      
2 Recurrent Eosinophilic Pneumonia Associated with Mesalazine Suppository in a Patient with Ulcerative Colitis
Myoungrin Park, Junguee Lee, Sang-Bum Kang, Yeonhee Park
Korean J Gastroenterol.2019;73(4):225-229.   Published online 2019 April 26     DOI: http://dx.doi.org/10.4166/kjg.2019.73.4.225
      
3 Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy–Access to Rapid Treatment (iSTART) approach
Silvio Danese, Rupa Banerjee, JR Fraser Cummings, Iris Dotan, Paulo G Kotze, Rupert Wing Loong Leong, Kristine Paridaens, Laurent Peyrin-Biroulet, Glyn Scott, Gert Van Assche, Jan Wehkamp, Jesús K Yamamoto-Furusho
Intest Res.2018;16(4):522-528.   Published online 2018 October 16     DOI: http://dx.doi.org/10.5217/ir.2018.00073
      
4 Comparison of efficacy of once daily multimatrix mesalazine 2.4 g/day and 4.8 g/day with other 5-aminosalicylic acid preparation in active ulcerative colitis: a randomized, double-blind study
Haruhiko Ogata, Tadashi Yokoyama, Seiichi Mizushima, Atsushi Hagino, Toshifumi Hibi
Intest Res.2018;16(2):255-266.   Published online 2018 April 30     DOI: http://dx.doi.org/10.5217/ir.2018.16.2.255
      
5 Comparison of efficacies of once-daily dose multimatrix mesalazine and multiple-dose mesalazine for the maintenance of remission in ulcerative colitis: a randomized, double-blind study
Haruhiko Ogata, Akihiro Ohori, Haruo Nishino, Seiichi Mizushima, Atsushi Hagino, Toshifumi Hibi
Intest Res.2017;15(3):358-367.   Published online 2017 June 12     DOI: http://dx.doi.org/10.5217/ir.2017.15.3.358
      
6 Comparison of efficacy of multimatrix mesalazine 4.8 g/day once-daily with other high-dose mesalazine in active ulcerative colitis: a randomized, double-blind study
Haruhiko Ogata, Nobuo Aoyama, Seiichi Mizushima, Atsushi Hagino, Toshifumi Hibi
Intest Res.2017;15(3):368-379.   Published online 2017 June 12     DOI: http://dx.doi.org/10.5217/ir.2017.15.3.368
      
7 A Case of Mesalazine-induced Eosinophilic Pneumonia in a Patient with Ulcerative Colitis
Ji Young Park, Hong Mo Kang, Su Young Kim, Yo Seb Han, Yong Seon Cho, Hyo Jong Kim, Jee Hong Yoo
Tuberc Respir Dis.2001;51(5):474-481.   Published online 2016 March 9     DOI: http://dx.doi.org/10.4046/trd.2001.51.5.474
      
8 Acute eosinophilic pneumonia related to a mesalazine suppository
Jung Hyun Kim, June-Hyuk Lee, Eun-Suk Koh, Sung woo Park, An-Soo Jang, Dojin Kim, Choon-Sik Park
Asia Pac Allergy.2013;3(2):136-139.   Published online 2013 April 26     DOI: http://dx.doi.org/10.5415/apallergy.2013.3.2.136
      
9 Recurrent Mesalazine-Induced Myopericarditis in a Patient with Ulcerative Colitis
Eun Hye Park, Byung Jin Kim, Jung Kwon Huh, Eun Haeng Jeong, Sang Hyuk Lee, Ki Bae Bang, Ji Soo Seol, Joo Wook Sung, Bum Soo Kim, Jin Ho Kang
J Cardiovasc Ultrasound.2012;20(3):154-156.   Published online 2012 September 21     DOI: http://dx.doi.org/10.4250/jcu.2012.20.3.154
      
10 A Case of Pyoderma Gangrenosum with Ulcerative Colitis Treated with Mesalazine
Jae In Lee, Hyun Jeong Park, Jun Young Lee, Baik Kee Cho
Ann Dermatol.2010;22(4):422-425.   Published online 2010 November 5     DOI: http://dx.doi.org/10.5021/ad.2010.22.4.422
      
11 A Case of Inferior Vena Cava Thrombosis and Acute Pancreatitis in a Patient with Ulcerative Colitis
Do Hyun Shin, Kwang Hyuk Lee, Chi Hoon Kim, Kap Hyun Kim, Sung Hyun Park, Dong Kyung Chang, Jong Kun Lee, Kyu Taek Lee
Korean J Gastroenterol.2010;56(4):255-259.   Published online 2010 February 21     DOI: http://dx.doi.org/10.4166/kjg.2010.56.4.255
   

 1 of 1